SHS Gesellschaft für Beteiligungsmanagement mbH
14. March 2022 -

Michael Bencak becomes new CEO of Swiss ndd Medical Technologies

ndd Medizintechnik AG is a global leader in diagnostic devices for the early detection of COPD and other lung diseases. The innovative products are also successfully used for the diagnosis of long-COVID. With Michael Bencak, ndd appoints an experienced medtech expert to drive the company forward in a tumultuous growth phase.

More information: https://t1p.de/vs6dc